Kingdon Capital Management »

X4 Pharmaceuticals shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 3.5M 0.84
2023-09-30 $2.2M 2.0M 1.09
2023-06-30 $3.8M 2.0M 1.94

More positions owned by Kingdon Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Blackstone Group Inc Com Cl A Put Option (BX)
Sherwin-Williams Company Call Option (SHW)
Api Group Corp Com Stk (APG)
Catalent (CTLT)
Rapt Therapeutics (RAPT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teck Resources CL B (TECK)
Meta Platforms Cl A (META)
Ftai Aviation SHS (FTAI)
Union Pacific Corporation (UNP)
Molson Coors Beverage CL B (TAP)
Synchrony Financial Put Option (SYF)
Bank of America Corporation Call Option (BAC)
Dell Technologies CL C (DELL)

View all positions for Kingdon Capital Management

Top funds holding X4 Pharmaceuticals

NEA Management Company
Vanguard Group
OrbiMed Advisors
Perceptive Advisors
Kingdon Capital Management
Citadel Advisors
Millennium Management
Point72 Asset Management
Schonfeld Strategic Advisors
Propel Bio Management
Barclays
Simplify Asset Management
Royce & Associates
Bank of New York Mellon
Charles Schwab Investment Management

View all funds holding X4 Pharmaceuticals